Cargando…
Antioxidant and Anti-Glycation Potential of H2 Receptor Antagonists—In Vitro Studies and a Systematic Literature Review
Background: Histamine H2 receptor antagonists are a group of drugs that inhibit gastric juice secretion in gastrointestinal diseases. However, there is evidence to suggest that H2 blockers have a broader spectrum of activity. The antioxidant properties of H2 blockers have not been fully elucidated,...
Autores principales: | Biedrzycki, Grzegorz, Wolszczak-Biedrzycka, Blanka, Dorf, Justyna, Michalak, Daniel, Żendzian-Piotrowska, Małgorzata, Zalewska, Anna, Maciejczyk, Mateusz |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10535796/ https://www.ncbi.nlm.nih.gov/pubmed/37765081 http://dx.doi.org/10.3390/ph16091273 |
Ejemplares similares
-
A New Insight into Meloxicam: Assessment of Antioxidant and Anti-Glycating Activity in In Vitro Studies
por: Pawlukianiec, Cezary, et al.
Publicado: (2020) -
The Influence of Two Priming Doses of Different Anti-COVID-19 Vaccines on the Production of Anti-SARS-CoV-2 Antibodies After the Administration of the Pfizer/BioNTech Booster
por: Wolszczak Biedrzycka, Blanka, et al.
Publicado: (2022) -
The effect of the third dose of the BNT162b2 vaccine on anti-SARS-CoV-2 spike antibody levels in healthcare workers with and without COVID-19 infection
por: Wolszczak-Biedrzycka, Blanka, et al.
Publicado: (2023) -
An Assessment of the Serum Activity of ADH and ALDH in Patients with Primary Biliary Cholangitis
por: Wolszczak-Biedrzycka, Blanka, et al.
Publicado: (2022) -
Anti-SARS-CoV-2S Antibody Levels in Healthcare Workers 10 Months after the Administration of Two BNT162b2 Vaccine Doses in View of Demographic Characteristic and Previous COVID-19 Infection
por: Wolszczak-Biedrzycka, Blanka, et al.
Publicado: (2022)